These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis. Zhao Q; Cheng W; Xi Y; Cao Z; Xu Y; Wu T; Li C; Niu X; Chen G Mol Immunol; 2018 Jan; 93():20-30. PubMed ID: 29127843 [TBL] [Abstract][Full Text] [Related]
3. LFA-1 Controls Th1 and Th17 Motility Behavior in the Inflamed Central Nervous System. Dusi S; Angiari S; Pietronigro EC; Lopez N; Angelini G; Zenaro E; Della Bianca V; Tosadori G; Paris F; Amoruso A; Carlucci T; Constantin G; Rossi B Front Immunol; 2019; 10():2436. PubMed ID: 31681316 [TBL] [Abstract][Full Text] [Related]
4. Lithium controls central nervous system autoimmunity through modulation of IFN-γ signaling. Rowse AL; Naves R; Cashman KS; McGuire DJ; Mbana T; Raman C; De Sarno P PLoS One; 2012; 7(12):e52658. PubMed ID: 23285134 [TBL] [Abstract][Full Text] [Related]
5. Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS. Kong W; Li H; Tuma RF; Ganea D Cell Immunol; 2014 Jan; 287(1):1-17. PubMed ID: 24342422 [TBL] [Abstract][Full Text] [Related]
6. Korean Red Ginseng and Ginsenoside-Rb1/-Rg1 Alleviate Experimental Autoimmune Encephalomyelitis by Suppressing Th1 and Th17 Cells and Upregulating Regulatory T Cells. Lee MJ; Jang M; Choi J; Chang BS; Kim DY; Kim SH; Kwak YS; Oh S; Lee JH; Chang BJ; Nah SY; Cho IH Mol Neurobiol; 2016 Apr; 53(3):1977-2002. PubMed ID: 25846819 [TBL] [Abstract][Full Text] [Related]
7. 4-Ethylguaiacol modulates neuroinflammation and Th1/Th17 differentiation to ameliorate disease severity in experimental autoimmune encephalomyelitis. Weng WT; Kuo PC; Brown DA; Scofield BA; Furnas D; Paraiso HC; Wang PY; Yu IC; Yen JH J Neuroinflammation; 2021 May; 18(1):110. PubMed ID: 33975618 [TBL] [Abstract][Full Text] [Related]
8. A novel human truncated IL12rβ1-Fc fusion protein ameliorates experimental autoimmune encephalomyelitis via specific binding of p40 to inhibit Th1 and Th17 cell differentiation. Guo W; Wang C; Wang X; Luo C; Yu D; Wang Y; Chen Y; Lei W; Gao X; Yao W Oncotarget; 2015 Oct; 6(30):28539-55. PubMed ID: 26384304 [TBL] [Abstract][Full Text] [Related]
11. Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis. Cummings M; Arumanayagam ACS; Zhao P; Kannanganat S; Stuve O; Karandikar NJ; Eagar TN PLoS One; 2018; 13(8):e0200752. PubMed ID: 30089166 [TBL] [Abstract][Full Text] [Related]
12. Dulaglutide Modulates the Development of Tissue-Infiltrating Th1/Th17 Cells and the Pathogenicity of Encephalitogenic Th1 Cells in the Central Nervous System. Chiou HC; Lin MW; Hsiao PJ; Chen CL; Chiao S; Lin TY; Chen YC; Wu DC; Lin MH Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934882 [TBL] [Abstract][Full Text] [Related]
13. The flavonoid kurarinone inhibits clinical progression of EAE through inhibiting Th1 and Th17 cell differentiation and proliferation. Xie L; Gong W; Chen J; Xie HW; Wang M; Yin XP; Wu W Int Immunopharmacol; 2018 Sep; 62():227-236. PubMed ID: 30031314 [TBL] [Abstract][Full Text] [Related]
14. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700 [TBL] [Abstract][Full Text] [Related]
15. STEAP4 expression in CNS resident cells promotes Th17 cell-induced autoimmune encephalomyelitis. Zhao J; Liao Y; Miller-Little W; Xiao J; Liu C; Li X; Li X; Kang Z J Neuroinflammation; 2021 Apr; 18(1):98. PubMed ID: 33879167 [TBL] [Abstract][Full Text] [Related]
16. Immunomodulation By Subchronic Low Dose 2,3,7,8-Tetrachlorodibenzo-p-Dioxin in Experimental Autoimmune Encephalomyelitis in the Absence of Pertussis Toxin. Yang EJ; Stokes JV; Kummari E; Eells J; Kaplan BL Toxicol Sci; 2016 May; 151(1):35-43. PubMed ID: 26822306 [TBL] [Abstract][Full Text] [Related]
17. The ribosomal S6 kinase inhibitor BI-D1870 ameliorated experimental autoimmune encephalomyelitis in mice. Takada I; Yogiashi Y; Makishima M Immunobiology; 2016 Feb; 221(2):188-92. PubMed ID: 26386981 [TBL] [Abstract][Full Text] [Related]
18. Simvastatin ameliorates experimental autoimmune encephalomyelitis by inhibiting Th1/Th17 response and cellular infiltration. de Oliveira DM; de Oliveira EM; Ferrari Mde F; Semedo P; Hiyane MI; Cenedeze MA; Pacheco-Silva A; Câmara NO; Peron JP Inflammopharmacology; 2015 Dec; 23(6):343-54. PubMed ID: 26559850 [TBL] [Abstract][Full Text] [Related]
19. A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis. Shen R; Deng W; Li C; Zeng G Int Immunopharmacol; 2015 Feb; 24(2):224-231. PubMed ID: 25528476 [TBL] [Abstract][Full Text] [Related]
20. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines. Lees JR; Iwakura Y; Russell JH J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]